What is the appropriate dosage of Augmentin (amoxicillin + clavulanate) for a 4‑year‑old boy weighing 38.1 kg with acute otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Augmentin Dosage for 4-Year-Old with Otitis Media

For this 4-year-old boy weighing 38.1 kg with acute otitis media, prescribe high-dose amoxicillin-clavulanate at 90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate, divided into 2 doses daily for 10 days.

Dosage Calculation

Based on the child's weight of 38.1 kg:

  • Total daily amoxicillin dose: 90 mg/kg × 38.1 kg = 3,429 mg/day
  • Per dose (twice daily): approximately 1,715 mg per dose
  • Total daily clavulanate: 6.4 mg/kg × 38.1 kg = 244 mg/day

This corresponds to the 14:1 ratio formulation (amoxicillin to clavulanate) recommended by guidelines 1.

Rationale for High-Dose Therapy

The 2013 American Academy of Pediatrics guidelines establish high-dose amoxicillin-clavulanate as first-line therapy for children with acute otitis media, particularly when 1:

  • The child has received amoxicillin in the previous 30 days
  • Concurrent purulent conjunctivitis is present
  • Coverage for β-lactamase-producing organisms (H. influenzae, M. catarrhalis) is desired

High-dose therapy (80-90 mg/kg/day) is specifically recommended to address penicillin-resistant S. pneumoniae, which remains a significant pathogen in AOM 1. Clinical trials demonstrate 96% eradication rates for S. pneumoniae and 91% eradication for penicillin-resistant strains with this regimen 2.

Important Clinical Considerations

Weight-Based Dosing Context

This child's weight (38.1 kg) is substantially above average for a 4-year-old (typical weight: 16-18 kg). Verify the weight is accurate before prescribing, as this will result in a very high absolute dose. If weight is confirmed correct, the calculation stands as above.

Formulation Selection

The Augmentin ES-600 formulation (600 mg amoxicillin/42.9 mg clavulanate per 5 mL) provides the optimal 14:1 ratio and is FDA-approved for this indication 3. This formulation reduces diarrhea risk compared to older 7:1 or 4:1 ratio preparations 1.

Treatment Duration

10 days of therapy is standard for children under 6 years with AOM 1. Clinical response should be evident within 48-72 hours; if symptoms persist or worsen, consider treatment failure and escalate therapy 1.

Common Pitfalls to Avoid

  • Do not use regular-dose amoxicillin-clavulanate (45 mg/kg/day) for initial therapy in this age group—it provides inadequate coverage for resistant organisms
  • Avoid older formulations with higher clavulanate ratios (7:1 or 4:1), which cause significantly more diarrhea without added benefit 1
  • Monitor for diarrhea: Protocol-defined diarrhea occurs in 11-13% of children on high-dose therapy 3, but this is acceptable given superior efficacy

If Treatment Fails

If no improvement occurs within 48-72 hours, switch to intramuscular ceftriaxone 50 mg/kg daily for 3 days 1. A 3-day course is superior to single-dose therapy for treatment failures 1.

The evidence strongly supports this high-dose regimen for optimal bacteriologic eradication and clinical cure rates in pediatric AOM, with acceptable safety profiles demonstrated in multiple large trials 3, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.